EP 2542540 A1 20130109 - POLYMORPH OF 2-[3-CYANO-4-(2-METHYLPROPOXY)PHENYL]-4-METHYLTHIAZOLE-5-CARBOXYLIC ACID
Title (en)
POLYMORPH OF 2-[3-CYANO-4-(2-METHYLPROPOXY)PHENYL]-4-METHYLTHIAZOLE-5-CARBOXYLIC ACID
Title (de)
POLYMORPH AUS 2-[3-CYANO-4-(2-METHYLPROPOXY)PHENYL]-4-METHYLTHIAZOL-5-CARBONSÄURE
Title (fr)
POLYMORPHE D'ACIDE 2-[3-CYANO-4-(2-MÉTHYLPROPOXY) PHÉNYL]-4-MÉTHYLTHIAZOLE-5-CARBOXYLIQUE
Publication
Application
Priority
- IN 488DE2010 A 20100304
- IB 2011050785 W 20110224
Abstract (en)
[origin: WO2011107911A1] The present invention provides crystalline Form R of 2-[3-cyano-4-(2- methylpropoxy) phenyl]-4-methylthiazole-5-carboxylic acid, process for its preparation, pharmaceutical composition comprising it and its use for the chronic management of hyperuricemia in patients with gout.
IPC 8 full level
C07D 277/56 (2006.01); A61K 31/426 (2006.01); A61P 19/06 (2006.01)
CPC (source: EP)
A61P 19/06 (2017.12); C07D 277/56 (2013.01)
Citation (search report)
See references of WO 2011107911A1
Citation (third parties)
Third party :
- CN 101412700 A 20090422 - SHANGHAI INST PHARM INDUSTRY [CN]
- CN 101085761 A 20071212 - SHANGHAI HUATUO MEDICAL SCIENC [CN]
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2011107911 A1 20110909; AU 2011222462 A1 20120927; CA 2792036 A1 20110909; EP 2542540 A1 20130109
DOCDB simple family (application)
IB 2011050785 W 20110224; AU 2011222462 A 20110224; CA 2792036 A 20110224; EP 11711672 A 20110224